Vapotherm Inc VAPO
We take great care to ensure that the data presented and summarized in this overview for VAPOTHERM INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding VAPO
View all-
Parian Global Management LP Pound Ridge, NY1.18MShares$2.49 Million6.0% of portfolio
-
Prescott Investors Profit Sharing Trust Boca Raton, FL86.4KShares$183,2670.29% of portfolio
-
River Vest Venture Management LLC St. Louis, MO52.9KShares$112,1070.86% of portfolio
-
Smith Thomas W Boca Raton, FL17.1KShares$36,3050.05% of portfolio
-
Brinker Capital Investments, LLC15.9KShares$33,6840.0% of portfolio
Latest Institutional Activity in VAPO
Top Purchases
Top Sells
About VAPO
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.
Insider Transactions at VAPO
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 01
2024
|
Elizabeth H Weatherman Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+25.47%
|
$60,000
$10.0 P/Share
|
Jan 01
2024
|
Donald J Spence Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+32.09%
|
$60,000
$10.0 P/Share
|
Jan 01
2024
|
Mary Beth Moynihan Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+31.54%
|
$50,000
$10.0 P/Share
|
Jan 01
2024
|
James W Liken Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+11.07%
|
$90,000
$10.0 P/Share
|
Jan 01
2024
|
Lori Lynn Knowles Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,750
+31.69%
|
$47,500
$10.0 P/Share
|
Jan 01
2024
|
Lance A Berry Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+19.06%
|
$60,000
$10.0 P/Share
|
Jan 01
2024
|
Anthony L. Arnerich Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,250
+15.0%
|
$52,500
$10.0 P/Share
|
Oct 02
2023
|
Brian Lawrence SVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+33.26%
|
-
|
Oct 02
2023
|
Dorota Mc Kay VP, Controller and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+41.24%
|
-
|
Oct 02
2023
|
John Landry SVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+22.65%
|
-
|
Sep 08
2023
|
Joseph Army President and CEO |
BUY
Open market or private purchase
|
Direct |
78,013
+9.44%
|
$234,039
$3.51 P/Share
|
Sep 07
2023
|
Joseph Army President and CEO |
BUY
Open market or private purchase
|
Direct |
21,987
+6.54%
|
$65,961
$3.31 P/Share
|
Aug 31
2023
|
Anthony L. Arnerich Director |
BUY
Open market or private purchase
|
Indirect |
20,000
+7.59%
|
$60,000
$3.17 P/Share
|
Aug 31
2023
|
Anthony L. Arnerich Director |
BUY
Open market or private purchase
|
Direct |
12,750
+15.08%
|
$38,250
$3.1 P/Share
|
Aug 30
2023
|
Anthony L. Arnerich Director |
BUY
Open market or private purchase
|
Direct |
5,000
+7.8%
|
$10,000
$2.9 P/Share
|
Aug 22
2023
|
Joseph Army President and CEO |
BUY
Open market or private purchase
|
Direct |
14,907
+4.86%
|
$44,721
$3.98 P/Share
|
Aug 21
2023
|
Joseph Army President and CEO |
BUY
Open market or private purchase
|
Direct |
27,604
+9.06%
|
$82,812
$3.62 P/Share
|
Aug 18
2023
|
Joseph Army President and CEO |
BUY
Open market or private purchase
|
Direct |
7,489
+2.91%
|
$22,467
$3.07 P/Share
|
Aug 15
2023
|
Joseph Army President and CEO |
BUY
Open market or private purchase
|
Direct |
61,182
+3.06%
|
$0
$0.42 P/Share
|
Aug 14
2023
|
Joseph Army President and CEO |
BUY
Open market or private purchase
|
Direct |
21,939
+1.16%
|
$0
$0.4 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 254K shares |
---|---|
Open market or private purchase | 488K shares |